Blood-Based Mutation Testing: Circulating Tumor Cells and Tumor DNA episode artwork

EPISODE · Jan 19, 2016 · 2 MIN

Blood-Based Mutation Testing: Circulating Tumor Cells and Tumor DNA

from GRACEcast · host cancerGRACE Meetings

Dr. Ed Kim from the Levine Cancer Institute reviews the potential advantages and current limitations of blood-based testing for molecular markers using circulating tumor cells and circulating tumor DNA in identifying clinically important mutations.

Episode metadata supplied by the publisher feed · Published Jan 19, 2016

Embed this episode

NOW PLAYING

Blood-Based Mutation Testing: Circulating Tumor Cells and Tumor DNA

0:00 2:49

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 2 minutes long.

When was this GRACEcast episode published?

This episode was published on January 19, 2016.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!